Log in | Register

Optima Group Invests Heavily: More Space, Latest Technology

For the latest pharmaceutical news and updates - Sign up now!
Loading...

Optima is investing approximately EUR 50 million in the sites in Schwäbisch Hall within the next two years. More than half will go into new buildings and large scale renovations on existing buildings. Upon completion in 2013, the utilizable space will have increased from 30,000 m2 to 50,000m2. Planning on future expansion, Optima has also purchased a 3 hectare plot of land.



At the same time, manufacturing, administration and research & development will be updated with the latest technology. EUR 25 million has been earmarked in the years 2011/2012 primarily for production machinery, and IT, with additional funds for bringing new technologies to market. Optima will profit from the synergies within the group.



During a celebration, Hans Bühler, the managing partner, made reference to a current pharma project which takes advantage of synergies. A EUR 15 million order, in which our competencies in sterile filling and pharmaceutical freeze drying are combined.



Optima information:


Since its founding in 1922, continuous growth has accompanied this mid-sized family business. With over 1,400 employees worldwide, Optima Group has consciously built customer focus by dividing the different business units according to their markets. Optima technologies are in demand worldwide, resulting in an export quotient of 80%. Highly reliable and innovative equipment for packaging single-serve solutions for coffee, packaging and palletising of paper hygiene products, turnkey systems for the pharmaceutical industry and flexible equipment for modern manufacture of wound care products are synonymous with the Optima name.

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Measles Infections on the Rise in the U.S.

Measles Infections on the Rise in the U.S.

Apr 20 | Video

Just over a decade ago, U.S. health officials believed measles would be eradicated, but according to a new report from the Centers for Disease Control, infections are back and the numbers are growing. Dr. Nancy Snyderman, NBC's Chief Medical Editor reports.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter